Carmat
Who owns Carmat?
Carmat is a French MedTech company, now owned by CARMAT SAS, which acquired it in 2025 from Truffle Capital.
Hand-verified · updated 2026-09-30
Open JSON · CC-BY
Key facts
- ·Fully exited in 2025 to CARMAT SAS.
- ·Average hold across 2 realized cycles: 11 years.
Ownership history
2 ownership periods · co-invest detected
Truffle Capital sold Carmat to CARMAT SAS in 2025 after 17 years.
Aliad Venture Capital sold CARMAT to Market in 2021 after 5 years.
More from Truffle Capital Legacy (pre-2019)
Other portfolio companies in the same fund.
France· 2017France· 2017France· 2017France· 2017France· 2017
France· 2016More PE-backed in MedTech
Comparable medtech deals from other GPs.
US
GermanyQuestions
Who owns Carmat?
Carmat is now owned by CARMAT SAS, which acquired it in 2025 from Truffle Capital.
When did CARMAT SAS acquire Carmat?
CARMAT SAS acquired Carmat in 2025, buying from Truffle Capital.
Who did Carmat sell to?
Truffle Capital sold Carmat to CARMAT SAS in 2025 (Trade Sale). Aliad Venture Capital sold Carmat to Market in 2021 (Trade Sale).
Who has owned Carmat over time?
Carmat has been through 2 private-equity ownership periods: Truffle Capital · via Truffle Capital Legacy (pre-2019) · 2008–2025 · sold to CARMAT SAS · (Trade Sale); Aliad Venture Capital · via ALIAD · 2016–2021 · sold to Market · (Trade Sale).